Institutional Fund
Ishara Investments LP
Los Angeles, CACIK 21116092 filings on record
Portfolio Value
$99.02M
Q1 2026
Holdings
36
Reported positions
New Buys
17
Opened this quarter
QoQ Change
+15.2%
from $85.92M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Praxis Precision Medicines I7.3%
- Axsome Therapeutics Inc7.0%
- Xeris Biopharma Holdings Inc6.0%
- Kalvista Pharmaceuticals Inc5.6%
- Amicus Therapeutics Inc5.4%
- Biomarin Pharmaceutical Inc4.7%
- Other64.0%
Portfolio Holdings
36 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Praxis Precision Medicines I | 22.6K | $7.27M | 7.3% | −17.4K | Reduced |
| 2 | Axsome Therapeutics Inc | 41.0K | $6.93M | 7.0% | +41.0K | New |
| 3 | Xeris Biopharma Holdings Inc | 1.02M | $5.95M | 6.0% | +225.0K | Added |
| 4 | Kalvista Pharmaceuticals Inc | 276.8K | $5.57M | 5.6% | +276.8K | New |
| 5 | Amicus Therapeutics Inc | 369.0K | $5.34M | 5.4% | +9.0K | Added |
| 6 | Biomarin Pharmaceutical Inc | 82.0K | $4.63M | 4.7% | −18.0K | Reduced |
| 7 | Verastem Inc | 820.0K | $4.35M | 4.4% | +550.0K | Added |
| 8 | Ultragenyx Pharmaceutical In | 174.3K | $3.65M | 3.7% | +124.3K | Added |
| 9 | Arrowhead Pharmaceuticals In | 55.4K | $3.47M | 3.5% | +55.4K | New |
| 10 | Vaxcyte Inc | 57.4K | $3.34M | 3.4% | +7.4K | Added |
26 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio